Related Experiment Video
Updated: Feb 22, 2026
10:19
Three-Dimensionally Printed Microfluidic Cross-flow System for Ultrafiltration/Nanofiltration Membrane Performance Testing
Published on: February 13, 2016
11.9K
Ultrafiltration in heart failure: Finding the entrance
1President of Hellenic Society of Cardiology, First Cardiology Clinic, Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese
|September 28, 2017
Summary
Ultrafiltration is a treatment for advanced heart failure with kidney injury. Choosing the best access site is crucial for effective chronic therapy, requiring careful patient assessment.
Area of Science:
- Nephrology
- Cardiology
- Renal Replacement Therapy
Background:
- Advanced heart failure frequently co-occurs with acute kidney injury or chronic kidney disease.
- Ultrafiltration offers a fluid management strategy for these complex patients.
- Optimal vascular access for ultrafiltration remains a critical consideration, particularly for long-term treatment.
Discussion:
- The choice of vascular access site impacts the efficacy and safety of ultrafiltration in heart failure patients.
- Patient-specific factors and treatment duration necessitate individualized access site selection.
- Effective communication between the clinical team and patient is paramount for successful chronic ultrafiltration therapy.
Key Insights:
- A prospective study investigated optimal vascular access for ultrafiltration in advanced heart failure with kidney injury.
- Findings provide evidence-based guidance for selecting the most appropriate access site.
- The study highlights the importance of patient evaluation in determining chronic treatment access.
Outlook:
- Further research is needed to refine best practices for vascular access in ultrafiltration therapy.
- Longitudinal studies can elucidate long-term outcomes associated with different access sites.
- Advancements in vascular access techniques may enhance ultrafiltration therapy for heart failure patients.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
430
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
430
01:22Heart Failure Drugs: Diuretics
1.1K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.1K
01:30Heart Failure V: Medical Management
392
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
392
01:25Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
262
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
262
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
257
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
257
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.2K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.2K